<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00347594</url>
  </required_header>
  <id_info>
    <org_study_id>GVC2-03-052</org_study_id>
    <nct_id>NCT00347594</nct_id>
  </id_info>
  <brief_title>A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)</brief_title>
  <official_title>A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the aberrations, corneal surface topography and
      pachymetry of normal human eyes with the NGDI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <primary_completion_date type="Actual">September 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of aberrations with the NGDI and the Zywave II.</measure>
    <time_frame>Single visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of corneal topography and pachymetry with the NGDI and the Orbscan IIz.</measure>
    <time_frame>Single visit</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Next Generation Diagnostic Instrument</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Next Generation Diagnostic Instrument (NGDI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Zyoptix Diagnostic Workstation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Zyoptix Diagnostic Workstation (ZDW)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Next Generation Diagnostic Instrument (NGDI)</intervention_name>
    <description>Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes</description>
    <arm_group_label>Next Generation Diagnostic Instrument</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zyoptix Diagnostic Workstation (ZDW)</intervention_name>
    <description>Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes</description>
    <arm_group_label>Zyoptix Diagnostic Workstation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  +10.00D to -20.00D of absolute spherical ametropia

          -  Must be part of the Bausch &amp; Lomb research clinic

          -  Snellen visual acuity must be correctable to 20/25

        Exclusion Criteria:

          -  No more than -6.00D of refractive astigmatism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele Lagana</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2006</study_first_submitted>
  <study_first_submitted_qc>June 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2006</study_first_posted>
  <last_update_submitted>January 15, 2014</last_update_submitted>
  <last_update_submitted_qc>January 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Corneal surface topography</keyword>
  <keyword>Ocular aberrations</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

